Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd

Company Profile

Product Certification&
Enterprise Certification

Country: China (Mainland)

Business Type: Trading Company

Ms.Wing Chen
Tel: +86-517-86283327

Mobile:
Tel:+86-517-86283327
Fax:+86-517-83715507
Province/state:Jiangsu
City:Huaian
Street:9 North Hantai Road, Huaian, China
MaxCard:

About us

Welcome To Our Site!
Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd is engaged in manufacturing and marketing APIs and advanced intermediates,we offer whole service on Capecitabine (USP31), Germcitabine HCl, Altretamine, Residronate Sodium, Febuxostat and other APIs.Also Chinese patent medicines and other Synthetic Finished Dosages whose types is drop pill, pill, tablet, capsule, dry suspension and granule.Our company is registered capital of RMB 48.96 million and located in Huai'an Economic Development Zone, Jiangsu province,which is a medium-sized integrated pharmaceutical enterprise jointly invested by Jiangsu Farms Co., Ltd (Group), Huai'an Hongda Investment & Consult Center, Beijing Chia Tai Green Continent Pharmaceutical Co.,Ltd and Jiangsu Juxin Investment Management Co., Ltd. We are comprised of 564 employees,including 183 technicians and professionals, 65 of whom possess medium or high grade professional titles.With the strict managerial system, advanced manufacturing establishment and integrated quality assurance system. Our company has successfully passed the first and second term of GMP validations,in 2004 and 2005 respectively,organized by the related food and drug administration bureau,and acquired the authentication certificate. The company has two departments including production department and R&D Department which offer whole service on Capecitabine (USP31), Germcitabine HCl, Altretamine, Residronate Sodium, Febuxostat and other APIs. One remarkable product of them is RuiyiTM Qingkailing Drop Pill, which has possessed authentication number as the first drop pill product in Jiangsu Province. The APIs of CTQJ specilize in anti-cancer, anti-osteoporotic, Anti-hyperuricemia and etc. All the APIs and Formulation drugs of CTQJ have been granted cGMP certificates by China SFDA. Gemcitabine Hydrochloride have been inspected and approved by KFDA in Aug, 2008 and SFDA in Oct, 2009. Adhering to the cocept of "people-centered", We are looking forward to promoting great cooperative relationships with customers from all over the world.